Clinical implications of genetic defects in G proteins: The molecular basis of McCune-Albright syndrome and Albright hereditary osteodystrophy

Medicine

Volumn 75, Issue 4, 1996, Pages 171-184

  Ringel, Matthew D ^a   Schwindinger, William F ^a   Levine, Michael A ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GUANINE NUCLEOTIDE BINDING PROTEIN; GUANOSINE TRIPHOSPHATASE;

ALBRIGHT SYNDROME; AMINO ACID SUBSTITUTION; CAFE AU LAIT SPOT; CARCINOGENESIS; CLINICAL FEATURE; ENDOCRINE DISEASE; GENE MUTATION; GENETIC DISORDER; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN STRUCTURE; PSEUDOHYPOPARATHYROIDISM; PSEUDOPSEUDOHYPOPARATHYROIDISM; REVIEW; SIGNAL TRANSDUCTION;

ADOLESCENT; ADULT; AGED; CHILD; CHILD, PRESCHOOL; FEMALE; FIBROUS DYSPLASIA, POLYOSTOTIC; GTP-BINDING PROTEINS; HUMANS; INFANT; MALE; MIDDLE AGED; MUTATION; PSEUDOHYPOPARATHYROIDISM; PSEUDOPSEUDOHYPOPARATHYROIDISM; SIGNAL TRANSDUCTION; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0029778906     PISSN: 00257974     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005792-199607000-00001     Document Type: Review

References (174)

1. Aarskog D, Tverteraas E. McCune-Albright's syndrome following adrenalectomy for Cushing's syndrome in infancy. J Pediatr 73: 89-96, 1968.
2. Abou-Samra AB, Jüppner H, Force T, Freeman MW, Kong XF, Schipani E, Urena P, Richards J, Bonventre JV, Potts JT Jr, Kronenberg HM, Segre GV. Expression cloning of a common receptor for parathyroid hormone and parathyroid hormone-related peptide from rat osteoblast-like cells: A single receptor stimulates intracellular accumulation of both cAMP and inositol trisphosphates and increases intracellular free calcium. Proc Natl Acad Sci U S A 89: 2732-36, 1992.
3. Abs R, Beckers A, Van de Vyver FL, De Schepper A, Stevenaert A, Hennen G. Acromegaly, multinodular goiter, and silent polyostotic dysplasia. A variant of the McCune-Albright syndrome. J Endocrinol Invest 13: 671-75, 1990.
4. Albin J, Wu R. Abnormal hypothalamic-pituitary function in polyostotic fibrous dysplasia. Clin Endocrinol 14: 435-43, 1981.
5. Albright F, Burnett CH, Smith PH. Pseudo-hypoparathyroidism: An example of "Seabright-Bantam syndrome." Endocrinology 30: 922-32, 1942.
6. Albright F, Butler AM, Hampton AO, Smith P. Syndrome characterized by osteitis fibrosa disseminata, areas of pigmentation, and endocrine dysfunction, with precocious puberty in females. N Engl J Med 216: 727-41, 1937.
7. Albright F, Forbes AP, Henneman PH. Pseudo-pseudohypoparathyroidism. Trans Assoc Am Physicians 65: 337-50, 1952.
8. Allgeier A, Offermanns S, Van Sande J, Spicher K, Schultz G, Dumont JE. The human thyrotropin receptor activates G-proteins Gs and Gq/11. J Biol Chem 269: 13733-35, 1994.
9. Benjamin D, McRoberts J. Polyostotic fibrous dysplasia associated with Cushing syndrome: Case report with autopsy findings. Arch Pathol 96: 175-78, 1973.
10. Benovic JL, DeBlasi A, Stone WC, Caron MG, Lefkowitz RJ. Beta-adrenergic receptor kinase: Primary structure delineates a multigene family. Science 246: 235-40, 1989.
11. Berlot CH, Bourne HR. Identification of effector-activating residues of Gsa. Cell 68: 911-22, 1992.
12. Birnbaumer L, Abramowitz J, Yatani A, Okabe K, Mattera R, Sanford J, Codina J, Brown AM. Roles of G proteins in coupling of receptors to ionic channels and other effector systems. Crit Rev Biochem Molec Bio 24: 225-44, 1990.
13. Boepple PA, Frisch LS, Wierman ME, Hoffman WH, Crowley WF. The natural history of autonomous gonadal function, adrenarche, and central puberty in gonadotropin-independent precocious puberty. J Clin Endocrinol Metab 75: 1550-55, 1992.
14. Boothroyd CV, Grimmond SM, Cameron DP, Hayward NK. G protein mutations in tumours of the pituitary, parathyroid and endocrine pancreas. Biochem Biophys Res Commun 211: 1063-70, 1995.
15. Boston BA, Mandel S, LaFranchi S, Bliziotes M. Activating mutation in the stimulatory guanine nucleotide-binding protein in an infant with Cushing's syndrome and nodular adrenal hyperplasia. J Clin Endocrinol Metab 79: 890-93, 1994.
16. Bourne HR, Sanders DA, McCormick F. The GTPase superfamily: Conserved structure and molecular mechanism. Nature 349: 117-27, 1991.
17. Bray P, Carter A, Simons C, Guo V, Puckett C, Kamholz J, Spiegel A, Nirenberg M. Human cDNA clones for four species of Gsa signal transduction protein. Proc Natl Acad Sci U S A 83: 8893-97, 1986.
18. Campbell R, Gosden CM, Bonthron DT. Parental origin of transcription from the human GNAS1 gene. J Med Genet 31: 607-14, 1994.
19. Carr D, Mathie IK, Manners AR. Hyperprolactinemia in a patient with the McCune-Albright syndrome. Br J Obstet Gynecol 86: 330-31, 1979.
20. Cavanah SF, Dons RF. McCune-Albright syndrome: How many endocrinopathies can one patient have? South Med J 86: 364-67, 1993.
21. Cerione RA, Sibley DR, Codina J, Benovic JL, Winslow J, Neer EJ, Birnbaumer L, Caron MG, Lefkowitz RJ. Reconstitution of a hormone-sensitive adenylate cyclase system. The pure beta-adrenergic receptor and guanine nucleotide regulatory protein confer hormone responsiveness on the resolved catalytic unit. J Biol Chem 259:9979-82, 1984.
22. Cerione RA, Staniszewski C, Benovic JL, Lefkowitz RJ, Caron MG, Gierschik P, Somers R, Spiegel AM, Codina J, Birnbaumer L. Specificity of the functional interactions of the beta-adrenergic receptor and rhodopsin with guanine nucleotide regulatory proteins reconstituted in phospholipid vesicles. J Biol Chem 260: 1493-1500, 1985.
23. Chanson P, Dib A, Visot A, Derome PJ. McCune-Albright syndrome and acromegaly: Clinical studies and responses to treatment in five cases. Eur J Endocrinol 131: 229-34, 1994.
24. Chase LR, Aurbach GD. Parathyroid function and the renal excretion of 3′5′-adenylic acid. Proc Natl Acad Sci U S A 58: 518-25, 1967.
25. Chase LR, Aurbach GD. The effect of parathyroid hormone on the concentration of adenosine 3′,5′-monophosphate in skeletal tissue in vitro. J Biol Chem 245: 1520-26, 1970.
26. Chase LR, Melson GL, Aurbach GD. Pseudohypoparathyroidism: Defective excretion of 3′,5′-AMP in response to parathyroid hormone. J Clin Invest 48: 1832-44, 1969.
27. Chen J, Iyengar R. Suppression of ras-induced transformation of NIH 3T3 cells by activated Gas. Science 263: 1278-81, 1994.
28. Chung KF, Alaghband-Zadeh J, Guz A. Acromegaly and hyperprolactinemia in McCune-Albright syndrome. Am J Dis Child 137: 134-36, 1983.
29. Civitelli R, Reid IR, Westbrook S, Avioli LV, Hruska KA. PTH elevates inositol polyphosphates and diacylglycerol in a rat osteoblast-like cell line. Am J Physiol 255: E660-E667, 1988.
30. Clapham DE, Neer EJ. New roles for G-protein βγ-dimers in transmembrane signalling. Nature 365: 403-6, 1993.
31. Clementi E, Malgaretti N, Meldolesi J, Taramelli R. A new constitutively activating mutation of the Gs protein a subunit-gsp oncogene is found in human pituitary tumours. Oncogene 5: 1059-61, 1990.
32. Coleman DE, Berghuis AM, Lee E, Linder ME, Gilman AG, Sprang SR. Structures of active conformations of Gia1 and the mechanism of GTP hydrolysis. Science 265: 1405-12, 1994.
33. Cremonini N, Graziano E, Chiarini V, Sforza A, Zampa GA. Atypical McCune-Albright syndrome associated with growth hormone-prolactin pituitary adenoma: Natural history, long-term follow-up, and SMS 201-995-bromocriptine combined treatment results. J Clin Endocrinol Metab 75: 1166-69, 1991.
34. Crespo P, Xu N, Simonds WF, Gutkind JS. Ras-dependent activation of MAP kinase pathway mediated by G-protein PT subunits. Nature 369: 418-20, 1994.
35. Cuttler L, Jackson JA, uz-Zafar MS, Levitsky L, Mellinger RC, Frohman LA. Hypersecretion of growth hormone and prolactin in McCune-Albright syndrome. J Clin Endocrinol Metab 68: 1148-54, 1989.
36. D'Armiento M, Reda G, Camagna A, Tardella L. McCune-Albright syndrome: Evidence for autonomous multiendocrine hyperfunction. J Pediatr 102: 584-86, 1983.
37. Danon M, Robboy S, Kim S, Scully R, Crawford J. Cushing syndrome, sexual precocity, and polycystic fibrous dysplasia (Albright syndrome) in infancy. J Pediatr 87: 917-21, 1975.
38. Davies SJ, Hughes HE. Imprinting in Albright's hereditary osteodystrophy. J Med Genet 30: 101-3, 1993.
39. Dhanasekaran N, Heasley LE, Johnson GL. G protein coupled receptor systems involved in cell growth and oncogenesis. Endocr Rev 16: 259-70, 1995.
40. Dunlay R, Hruska K. PTH receptor coupling to phospholipase C is an alternate pathway of signal transduction in bone and kidney. Am J Physiol 258: F223-F231, 1990.
41. Econs MJ, Drezner MK. Tumor-induced osteomalacia - unveiling a new hormone. N Engl J Med 330: 1679-81, 1994.
42. Ehrig U, Wilson D. Fibrous dysplasia of bone and primary hyperparathyroidism. Ann Intern Med 77: 234-38, 1972.
43. Endo M, Yamada Y, Matsuura N, Niikawa N. Monozygotic twins discordant for the major signs of McCune-Albright syndrome. Am J Med Genet 41: 216-20, 1991.
44. Falconer MA, Cope CL, Robb-Smith AHT. Fibrous dysplasia of bone with endocrine disorders and cutaneous pigmentation (Albright's disease). Q J Med 11: 121-56, 1942.
45. Feuillan PP, Foster CM, Pescovitz OH, Hench KD, Shawker RT, Dwyer A, Malley JD, Barnes K, Loriaux DL, Cutler GB. Treatment of precocious puberty in the McCune-Albright syndrome with the aromatase inhibitor testalactone. N Engl J Med 315: 1115-19, 1986.
46. Feuillan PP, Jones J, Cutler GB. Long term testalactone therapy for precocious puberty in girls with the McCune-Albright syndrome. J Clin Endocrinol Metab 77: 647-51, 1993.
47. Feuillan PP, Jones J, Ross JL. Growth hormone hypersecretion in a girl with McCune-Albright syndrome: Comparison with controls and response to a dose of long-acting somatostatin analog. J Clin Endocrinol Metab 80: 1357-60, 1995.
48. Feuillan PP, Shawker T, Rose SR, Jones J, Jeevanram RK, Nisula BC. Thyroid abnormalities in the McCune-Albright syndrome: Ultrasonography and hormonal studies. J Clin Endocrinol Metab 71: 1596-1601, 1990.
49. Foster CM, Ross JL, Shawker T, Pescovitz OH, Loriaux DL, Cutler GB, Comite F. Absence of pubertal gonadotropin secretion in girls with McCune-Albright syndrome. J Clin Endocrinol Metab 58: 1161-65, 1984.
50. Frisch LS, Copeland KC, Boepple PA. Recurrent ovarian cysts in childhood: Diagnosis of McCune-Albright syndrome by bone scan. Pediatr 90: 102-4, 1992.
51. Fukada Y, Ohguro H, Saito T, Yoshizawa T, Aldno T. βγ-subunit of bovine transducin composed of two components with distinctive γ-subunits. J Biol Chem 264: 5937-43, 1989.
52. Geffner ME, Nagel RA, Dietrich RB, Kaplan SA. Treatment of acromegaly with a somatostatin analog in a patient with McCune-Albright syndrome. J Pediatr 111: 740-43, 1987.
53. Gilman AG. G proteins and dual control of adenylate cyclase. Cell 36: 577-79, 1984.
54. Gilman AG. Guanine nucleotide-binding regulatory proteins and dual control of adenylate cyclase. J Clin Invest 73: 1-4, 1984.
55. Goretzki PE, Lyons J, Stacy-Phipps S, Rosenau W, Demeure M, Clark OH, McCormick F, Roher H-D, Bourne HR. Mutational activation of ras and gsp oncogenes in differentiated thyroid cancer and their biological imputations. World J Surg 16: 576-82, 1992.
56. Goretzki PE, Simon D, Roher H-D. G-protein mutations in thyroid tumors. Exp Clin Endocrinol 100: 14-16, 1992.
57. Graziano MP, Gilman AG. Synthesis in Escherichia coli of GTPase-deflcient mutants of Gsa. J Biol Chem 264: 15475-82, 1989.
58. Guo J, Iida-Klein A, Huang X, Abou-Samra AB, Segre GV, Bringhurst FR. Parathyroid hormone (PTH)/PTH-related peptide receptor density modulates activation of phospholipase C and phosphate transport by PTH in LLC-PK1 cells. Endocrinology 136: 3884-91, 1995.
59. Hahn SB, Lee SB, Kim DH. Albright's syndrome with hypophosphatemic rickets and hyperthyroidism - a case report. Yonsei Med J 32: 179-83, 1991.
60. Happle R. The McCune-Albright syndrome: A lethal gene surviving by mosaicism. Clin Genet 29: 321-24, 1986.
61. Harris RI. Polyostotic fibrous dysplasia with acromegaly. Am J Med 78: 539-42, 1985.
62. Harris WH, Dudley HR, Barry RJ. The natural history of fibrous dysplasia. J Bone Joint Surg 44-A: 207-33, 1962.
63. Hauffa BP, Havers W, Stolecke H. Short-term effects of testalactone compared to other treatment modalities on longitudinal growth and ovarian activity in a girl with McCune-Albright syndrome. Helv Paediatr Acta 42: 471-80, 1987.
64. Hausdorff WP, Hnatowich M, O'Dowd BF, Caron MG, Lefkowitz RJ. A mutation of the beta 2-adrenergic receptor impairs agonist activation of adenylyl cyclase without affecting high affinity agonist binding. Distinct molecular determinants of the receptor are involved in physical coupling to and functional activation of Gs. J Biol Chem 265: 1388-93, 1990.
65. Hellevuo K, Yoshimura M, Kao M, Hoffman PL, Cooper DMF, Tabakoff B. A novel adenylyl cyclase sequence cloned from the human erythroleukemia cell line. Biochem Biophys Res Commun 192: 311-18, 1993.
66. Huang TS, Chang CC, Huang JS, Hsieh HC, Chen FW. Albright's syndrome with acromegaly and Hashimoto's thyroiditis: Report of a case. J Formos Med Assoc 89: 714-18, 1990.
67. Iiri T, Herzmark P, Nakamoto JM, Dop CV, Bourne HR. Rapid GDP release from Gsα in patients with gain and loss of endocrine function. Nature 371: 164-68, 1994.
68. Inamo Y, Hanawa Y, Kin H, Okuni M. Findings on magnetic resonance imaging of the spine and femur in a case of McCune-Albright syndrome. Pediatr Radiol 23: 15-18, 1993.
69. sα mRNA. J Biol Chem 265: 8458-62, 1990.
70. Johnson WG. Metabolic interference and the +- heterozygote. A hypothetical form of simple inheritance which is neither dominant nor recessive. Am J Hum Genet 32: 374-86, 1980.
71. Joishy SK, Morrow LB. McCune-Albright syndrome associated with a functioning pituitary chromophobe adenoma. J Pediatr 89: 73-75, 1976.
72. Journot L, Pantaloni C, Bockaert J, Audigier Y. Deletion within the amino-terminal region of Gsa impairs its ability to interact with βγ subunits and to activate adenylate cyclase. J Biol Chem 266: 9009-15, 1991.
73. Kahn RA, Gilman AG. ADP-ribosylation of Gs promotes the dissociation of its α and β subunits. J Biol Chem 259: 6235-40, 1984.
74. Karaplis AC, Luz A, Glowacki J, Bronson RT, Tybulewicz VLJ, Kronenberg HM, Mulligan RC. Lethal skeletal dysplasia from targeted disruption of the parathyroid hormone-related peptide gene. Genes Dev 8: 277-89, 1994.
75. Katada T, Bokoch GM, Northup JK, Ui M, Gilman AG. The inhibitory guanine nucleotide-binding regulatory component of adenylate cyclase. Properties and function of the purified protein. J Biol Chem 259: 3568-77, 1984.
76. Kehlenbach RH, Matthey J, Huttner WB. XLas is a new type of G protein. Nature 372: 804-8, 1994.
77. Kessel D, Hall CM, Shaw DG. Two unusual cases of nephrocalcinosis in infancy. Pediatr Radiol 22: 470-71, 1992.
78. Kim D, Lewis DL, Graziadei L, Neer EJ, Bar-Sagi D, Clapham DE. G-protein βγ-subunits activate the cardiac muscarinic potassium channel via phospholipase A2. Nature 337: 557, 1989.
79. Kleuss C, Scherubl H, Hescheler J, Schultz G, Wittig B. Different β-subunits determine G-protein interactions with transmembrane receptors. Nature 358: 424-26, 1992.
80. Kovacs K, Horvath E, Thorner MO, Rogol AD. Mammosomatotroph hyperplasia associated with acromegaly and hyperprolactinemia in a patient with the McCune-Albright syndrome. Virchows Archiv (Pathol Anat) 403: 77-86, 1984.
81. Kozasa T, Itoh H, Tsukamoto T, Kaziro Y. Isolation and characterization of the human Gsa gene. Proc Natl Acad Sci U S A 85: 2081-85, 1988.
82. Kumawat DC, Bomb BS, Agarwal HK, Bhatnagar HNS. The Albright syndrome associated with acromegaly and hyperthryoidism (a case report). J Postgrad Med 33: 155-57, 1987.
83. Kupcha PC, Guille JT, Tassanawipas A, Bowen JR. Polyostotic fibrous dysplasia and acromegaly. J Pediatr Orthop 11: 95-99, 1991.
84. Lambright DG, Noel JP, Hamm HE, Sigler PB. Structural determinants for activation of the α-subunit of a heterotrimeric G protein. Nature 369: 621-28, 1994.
85. Landis CA, Harsh G, Lyons J, Davis RL, McCormick F, Bourne HR. Clinical characteristics of acromegalic patients whose pituitary tumors contain mutant Gs protein. J Clin Endocrinol Metab 71: 1416-20, 1990.
86. Landis CA, Masters SB, Spada A, Pace AM, Bourne HR, Vallar L. GTPase inhibiting mutations activate the a chain of Gs and stimulate adenylyl cyclase in human pituitary tumours. Nature 340:692-96, 1989.
87. Ledent C, Dumont JE, Vassart G, Parmentier M. Thyroid expression of an A2 adenosine receptor transgene induces thyroid hyperplasia and hyperthyroidism. EMBO J 11: 537-42, 1992.
88. Lee PA, Van Dop C, Migeon CJ. McCune-Albright syndrome. Long term follow-up. JAMA 256: 2980-84, 1986.
89. Lester PD, McAlister WH. Fibrous dysplasia and precocious puberty (McCune-Albright syndrome). South Med J 72: 631-32, 1979.
90. Lever EG, Pettingale KW. Albright's syndrome associated with a soft-tissue myxoma and hypophosphatemic osteomalacia. J Bone Joint Surg 65B: 621-26, 1983.
91. Levine MA, Ann TG, Klupt SF, Kaufman KD, Smallwood PM, Bourne HR, Sullivan KA, Van Dop C. Genetic deficiency of the a subunit of the guanine nucleotide-binding protein Gs as the molecular basis for Albright hereditary osteodystrophy. Proc Natl Acad Sci U S A 85: 617-21, 1988.
92. Levine MA, Downs EW Jr, Moses AM, Breslau NA, Marx SJ, Lasker RD, Rizzoli RE, Aurbach GD, Spiegel AM. Resistance to multiple hormones in patients with pseudohypoparathyroidism. Association with deficient activity of guanine nucleotide regulatory protein. Am J Med 74: 545-56, 1983.
93. Levine MA, Jap TS, Hung W. Infantile hypothyroidism in two sibs: An unusual presentation of pseudohypoparathyroidism type Ia. J Pediatr 107: 919-22, 1985.
94. Levine MA, Jap TS, Mauseth RS, Downs RW, Spiegel AM. Activity of the stimulatory guanine nucleotide-binding protein is reduced in erythrocytes from patients with pseudohypoparathyroidism and pseudopseudohypoparathyroidism: Biochemical, endocrine, and genetic analysis of Albright's hereditary osteodystrophy in six kindreds. J Clin Endocrinol Metab 62: 497-502, 1986.
95. Levine MA, Modi WS, O'Brien SJ. Mapping of the gene encoding the α subunit of the stimulatory G protein of adenylyl cyclase (GNASI) to 20q13.2→q13.3 in human by in situ hybridization. Genomics 11: 478-79, 1991.
96. Levine MA, Smallwood PM, Moen PT Jr, Helman LJ, Ahn TG. Molecular cloning of β3 subunit, a third form of the G protein β-subunit polypeptide. Proc Natl Acad Sci U S A 87: 2329-33, 1990.
97. Levitzki A, Rudick J, Pastan I, Vass WC, Lowy DR. Adenylate cyclase activity of NIH 3T3 cells morphologically transformed by ras genes. FEBS Lett 197: 134-38, 1986.
98. Lightner ES, Penny R, Frasier SD. Growth hormone excess and sexual precocity in polyostotic fibrous dysplasia (McCune-Albright syndrome): Evidence for abnormal hypothalamic function. J Pediatr 87: 922-27, 1975.
99. Lipson A, Hsu T-H. The Albright syndrome associated with acromegaly: Report of a case and review of the literature. Johns Hopkins Med J 149: 10-14, 1981.
100. Lyons J, Landis CA, Griffith H, Vallar L, Grunewald K, Feichtinger H, Duh QY, Clark OH, Kawasaki E, Bourne HR, McCormick F. Two G protein oncogenes in human endocrine tumors. Science 249: 655-59, 1990.
101. Majzoub JA, Scully RE. A six-year-old boy with multiple bone lesions, repeated fractures, and sexual precocity. N Engl J Med 328: 496-502, 1993.
102. Malchoff CD, Reardon G, MacGillivray DC, Yamase H, Rogol AD, Malchoff DM. An unusual presentation of McCune-Albright syndrome confirmed by an activating mutation of the Gsa-subunit from a bone lesion. J Clin Endocrinol Metab 78: 803-6, 1994.
103. Manna C, Epifano O, Riminucci M, Baschieri L, Stefanini M, Canipari R. In vitro production of estradiol by ovarian granulosa cells in a case of McCune-Albright syndrome. J Endocrinol Invest 14: 311-15, 1991.
104. Masters SB, Sullivan KA, Miller RT, Beiderman B, Lopez NG, Ramachandran J, Bourne HR. Carboxyl terminal domain of Gsa specifies coupling of receptors to stimulation of adenylyl cyclase. Science 241: 448-51, 1988.
105. Matsuo K, Friedman E, Gejman P, Fagin J. The thyrotropin receptor (TSH-R) is not an oncogene for thyroid tumors: Structural studies of the TSH-R and the a-subunit of Gs in human thyroid neoplasms. J Clin Endocrinol Metab 76: 1446-51, 1993.
106. Mauras N, Blizzard RM. The McCune Albright syndrome. Acta Endocrinol 256 Suppl: 207-17, 1986.
107. McCune DJ, Bruch H. Osteodystrophia fibrosa. Am J Dis Child 54: 806-48, 1937.
108. Meinkoth JL, Goldsmith PK, Spiegel AM, Feramisco JR, Burrow GN. Inhibition of thyrotropin-induced DNA synthesis in thyroid follicular cells by microinjection of an antibody to the stimulatory G protein of adenylate cyclase, Gs. J Biol Chem 267: 13239-45, 1992.
109. Michiels F, Caillou B, Talbot M, Dessarps-Freichey F, Maunoury M-T, Schlumberger M, Mercken L, Monier R, Feunteun J. Oncogenic potential of guanine nucleotide stimulatory factor α subunit in thyroid glands of transgenic mice. Proc Natl Acad Sci U S A 91: 10488-92, 1994.
110. Miric A, Vechio JD, Levine MA. Heterogeneous mutations in the gene encoding the α-subunit of the stimulatory G protein of adenylyl cyclase in Albright hereditaiy osteodystrophy. J Clin Endocrinol Metab 76: 1560-68, 1993.
111. Misaki M, Shima T, Ikoma J, Morioka K, Suzuki S. Acromegaly and hyperthryoidism associated with McCune-Albright syndrome. Horm Res 30: 26-27, 1988.
112. Moses AM, Weinstock RS, Levine MA, Breslau NA. Evidence for normal antidiuretic responses to endogenous and exogenous arginine vasopressin in patients with guanine nucleotide-binding stimulatory protein-deficient pseudohypoparathyroidism. J Clin Endocrinol Metab 62: 221-24, 1986.
113. Nakamoto JM, Jones EA, Zimmerman D, Scott ML, Donlan MA, Van Dop C. A missense mutation in the Gsa gene is associated with pseudohypoparathyroidism type I-A (PHP I-A) and gonadotropin-independant precocious puberty (GIPP). Clin Res 41: 40A, 1993.
114. Nemoz G, Sette C, Hess M, Muca C, Vallar L, Conti M. Activation of cyclic nucleotide phosphodiesterases in FRTL-5 thyroid cells expressing a constitutively active Gs alpha. Mol Endocrinol 9: 1279-87, 1995.
115. Noel JP, Hamm HE, Sigler PB. The 2.2 A cyrstal structure of transducin-a complexed with GTPgS. Nature 366: 654-63, 1993.
116. Nomura N, Miyajima N, Sazuka T, Tanaka A, Kawarabayasi Y, Sato S, Nagase T, Seid N, Ishikawa K, Tabata S. Prediction of the coding sequences of unidentified human genes. I. The coding sequences of 40 new genes (KIAA0001-KIAA0040) deduced by analysis of randomly sampled cDNA clones from human immature myeloid cell line KG-1. DNA Res 1: 27-35, 1994.
117. O'Sullivan C, Barton CM, Staddon SL, Brown CL, Lemoine NR. Activating point mutations of the gsp oncogene in human thyroid adenomas. Mol Carcinogenesis 4: 345-49, 1991.
118. Osawa S, Dhanasekaran N, Woon CW, Johnson GL. Gαi-Gαs chimeras define the function of a chain domains in control of G protein activation and βγ subunit complex interactions. Cell 63: 697-706, 1990.
119. Ostrowski J, Kjelsberg MA, Caron MG, Lefkowitz RJ. Mutagenesis of the beta 2-adrenergic receptor: How structure elucidates function. Annu Rev Pharmacol Toxicol 32: 167-83, 1992.
120. Oude Luttikhuis MEM, Wilson LC, Leonard JV, Trembath RC. Characterization of a de novo 43-bp deletion of the Gsa gene (GNAS1) in Albright hereditary osteodystrophy. Genomics 21: 455-57, 1994.
121. Pacini F, Perri G, Bagnolesi P, Cilotti A, Pinchera A. McCune-Albright syndrome with gigantism and hyperprolactinemia. J Endocrinol Invest 10: 417-20, 1987.
122. Patten JL, Johns DR, Valle D, Eil C, Gruppuso PA, Steele G, Smallwood PM, Levine MA. Mutation in the gene encoding the stimulatory G protein of adenylate cyclase in Albright's hereditary osteodystrophy. N Engl J Med 322: 1412-19, 1990.
123. Patten JL, Levine MA. Immunochemical analysis of the α-subunit of the stimulatory G-protein of adenylyl cyclase in patients with Albright's hereditary osteodystrophy. J Clin Endocrinol Metab 71: 1208-14, 1990.
124. Phelan MC, Rogers C, Clarkson KB, Bowyer FP, Levine MA, Estabrooks LL, Severson MC, Dobyns WB. Albright hereditary osteodystrophy and del(2)(q37.3) in four unrelated individuals. Am J Med Genet 58: 1-7, 1995.
125. Pitcher J, Lohse MJ, Codina J, Caron MG, Lefkowitz RJ. Desensitization of the isolated beta 2-adrenergic receptor by beta-adrenergic receptor kinase, cAMP-dependent protein kinase, and protein kinase C occurs via distinct molecular mechanisms. Biochemistry 31: 3193-97, 1992.
126. Pitcher JA, Inglese J, Higgins JB, Arriza JL, Casey PJP, Kim C, Benovic JL, Kwatra MM, Caron MG, Lefkowitz RJ. Role of βγ subunits of G proteins in targeting the beta-adrenergic receptor kinase to membrane bound-receptors. Science 257: 1264-67, 1992.
127. Polychronakos C, Tsoukas G, Ducharme JR, Letarte J, Collu R. Gigantism and hyperprolactinemia in polyostotic fibrous dysplasia (McCune-Albright syndrome). J Endocrinol Invest 5: 323-26, 1982.
128. Powell DGB. Polyostotic fibrous dysplasia with acromegaly (Albright's syndrome): A case report. S Afr Med J 50: 182, 1976.
129. Prayson MA, Leeson MC. Soft-tissue myxomas and fibrous dysplasia of bone: A case report and review of the literature. Clin Orthop Rel Res 291: 222-28, 1993.
130. Premawardhana LDKE, Vora JP, Mills R, Scanlon MF. Acromegaly and its treatment in the McCune-Albright syndrome. Clin Endocrinol 36: 605-8, 1992.
131. Pronk GL, Bos JL. The role of p21 ras in receptor tyrosine kinase signalling. Biochim Biophys Acta 1198: 131-47, 1994.
132. Pun KK, Chan G, Kung A, Lam K, Chan FL, Wang C. McCune-Albright syndrome with acromegaly. Horm Metab Res 21: 527-28, 1989.
133. Rahmatullah M, Ginnan R, Robishaw JD. Specificity of G Protein α-γ subunit interactions. J Biol Chem 270: 2946-51, 1995.
134. Rahmatullah M, Robishaw JD. Direct interaction of the α and γ sub-units of the G proteins. J Biol Chem 269: 3574-80, 1994.
135. Rhee SG, Cnol KD. Regulation of inositol phospholipid-specific phospholipase C isozymes. J Biol Chem 267: 12393-96, 1992.
136. Ruggieri P, Sim FH, Bond JR, Unni KK. Malignancies in fibrous dysplasia. Cancer 73: 1411-24, 1994.
137. Schipani E, Weinstein LS, Bergwitz C, Iida-Hein A, Kong XF, Stuhrmann M, Kruse K, Whyte MP, Murray T, Schmidtke J, Van Dop C, Brickman AS, Crawford JD, Potts JT Jr, Kronenberg HM, Segre GV, Jüppner H. Pseudohypoparathyroidism type Ib is not caused by mutations in the coding exons of the human parathyroid hormone (PTH)/PTH-related peptide receptor gene. J Clin Endocrinol Metab 80:1611-21, 1995.
138. Schmidt CJ, Neer EJ. In vitro synthesis of G protein β γ dimers. J Biol Chem 266: 4538-44, 1991.
139. Schmidt CJ, Thomas TC, Levine MA, Neer EJ. Specificity of G protein β and γ subunit interactions. J Biol Chem 267: 13807-10, 1992.
140. Schuster V, Kress W, Kruse K. Paternal and maternal transmission of pseudohypoparathyroisism type Ia in a family with Albright hereditary osteodystrophy: No evidence of genomic imprinting [letter]. J Med Genet 31: 84, 1994.
141. Schwindinger WF, Francomano CA, Levine MA. Identification of a mutation in the gene encoding the a subunit of the stimulatory G protein of adenylyl cyclase in McCune-Albright syndrome. Proc Natl Acad Sci U S A 89: 5152-56, 1992.
142. sα mutant in a patient with Albright hereditary osteodystrophy uncouples cell surface receptors from adenylyl cyclase. J Biol Chem 269: 25387-91, 1994.
143. Scully RE, Mark EJ, McNeely WF, McNeely BU, eds. Case records of the Massachusetts General Hospital: Case 7-1993. N Engl J Med 328: 496-502, 1993.
144. Scurry MT, Bicknell JM, Fajans SS. Polyostotic fibrous dysplasia and acromegaly. Arch Intern Med 114: 40-45, 1964.
145. sα mutation is present in fibrous dysplasia of bone in the McCune-Albright syndrome. J Clin Endocrinol Metab 79: 750-75, 1994.
146. Shenker A, Weinstein LS, Moran A, Pescovitz OH, Charest NJ, Boney CM, Van Wyk JJ, Merino MJ, Feuillan PP, Spiegel AM. Severe endocrine and nonendocrine manifestations of the McCune-Albright syndrome associated with activating mutations of the stimulatory G protein Gs. J Pediatr 123: 509-18, 1993.
147. Sherman SI, Ladenson PW. Octreotide therapy of growth hormone excess in the McCune-Albright syndrome. J Endocrinol Invest 15: 185-90, 1992.
148. Shih TY, Hattori S, Clanton DJ, Ulsh LS, Chen ZQ, Lautenberger JA, Papas TS. Structure and function of p21 ras proteins. Gene Amplif Anal 4: 53-72, 1986.
149. Sibley DR, Lefkowitz RJ. Beta-adrenergic receptor-coupled adenylate cyclase. Biochemical mechanisms of regulation. Mol Neurobiol 1:121-54, 1987.
150. Spada A, Arosio M, Bochicchio D, Bazzoni N, Vallar L, Bassetti M, Faglia G. Clinical, biochemical, and morphological correlates in patients bearing growth hormone-secreting pituitary tumors with or without constitutively active adenylyl cyclase. J Clin Endocrinol Metab 71: 1421-26, 1990.
151. Suarez HG, du Villard JA, Caillou B, Schlumberger M, Parmentier C, Monier R. Gsp mutations in human thyroid tumours. Oncogene 6: 677-79, 1991.
152. Swislocki AL, Camargo CA, Hoffman AR. McCune-Albright Syndrome: A case of primary hypogonadism obscured by hyperprolactinemic hypogonadotropic hypogonadism. West J Med 153: 653-56, 1990.
153. Tang WJ, Gilman AG. Type-specific regulation of adenylyl cyclase by G protein βγ subunits. Science 254: 1500-3, 1991.
154. Taussig R, Gilman AG. Mammalian membrane-bound adenylyl cyclases. J Biol Chem 270: 1-4, 1995.
155. Tordjman K, Stern N, Ouaknine G, Yossiphov Y, Razon N, Nordenskjold M, Friedman E. Activating mutations of the Gs alpha-gene in nonfunctioning pituitary tumors. J Clin Endocrinol Metab 77: 765-69, 1993.
156. Triantafillidou K, Antoniades K, Karakasis D, Rousso I, Drevelegas A. McCune-Albright syndrome: Report of a case. Oral Surg Oral Med Oral Pathol 75: 571-74, 1993.
157. Usdin TB, Gruber C, Bonner TI. Identification and functional expression of a receptor selectively recognizing parathyroid hormone, the PTH2 receptor. J Biol Chem 270: 15455-58, 1995.
158. Vallar L, Spada A, Giannattasio G. Altered Gs and adenylate cyclase activity in human GH-secreting pituitary adenomas. Nature 330: 566-68, 1987.
159. Van Dop C, Bourne HR, Neer RM. Father to son transmission of decreased Ns activity in pseudohypoparathyroidism type Ia. J Clin Endocrinol Metab 59: 825-28, 1984.
160. Van Sande J, Raspe E, Perret J, Lejeune C, Maenhaut C, Vassart G, Dumont JE. Thyrotropin activates both the cyclic AMP and the PIP2 cascades in CHO cells expressing the human cDNA of TSH receptor. Mol Cell Endocrinol 74: R1-R6, 1990.
161. Vessey SJ, Jones PM, Wallis SC, Schofield J, Bloom SR. Absence of mutations in the Gs alpha and Gi2 alpha genes in sporadic parathyroid adenomas and insulinomas. Clin Sci 87: 493-97, 1994.
162. Watson AJ, Katz A, Simon MI. A fifth member of the mammalian G-protein β-subunit family. J Biol Chem 269: 22150-56, 1994.
163. Wedegaertner PB, Wilson PT, Bourne HR. Lipid modifications of trimeric G proteins. J Biol Chem 270: 503-6, 1995.
164. Weinstein LS, Gejman PV, de Mazancourt P, American N, Spiegel AM. A heterozygous 4-bp deletion mutation in the Gsa gene (GNAS1) in a patient with Albright hereditary osteodystrophy. Genomics 13:1319-21, 1992.
165. Weinstein LS, Gejman PV, Friedman E, Kadowaki T, Collins RM, Gershon ES, Spiegel AM. Mutations of the Gs α-subunit gene in Albright hereditary osteodystrophy detected by denaturing gradient gel electrophoresis. Proc Natl Acad Sci U S A 87: 8287-90, 1990.
166. Weinstein LS, Shenker A, Gejman PV, Merino MJ, Friedman E, Spiegel AM. Activating mutations of the stimulatory G protein in the McCune-Albright syndrome. N Engl J Med 325: 1688-95, 1991.
167. Williamson EA, Daniels M, Foster S, Kelly WF, Kendall-Taylor P, Harris PE. Gs alpha and Gi2 alpha mutations in clinically non-functioning pituitary tumors. Clin Endocrinol 41: 815-20, 1994.
168. Williamson EA, Ince PG, Harrison D, Kendall-Taylor P, Harris PE. G protein mutations in human pituitary adrenocorticotrophic hormone-secreting adenomas. Eur J Clin Invest 25: 128-31, 1995.
169. Williamson EA, Johnson SJ, Foster S, Kendall-Taylor P, Harris PE. G Protein mutations in patients with multiple endocrinopathies. J Clin Endocrinol Metab 80: 1702-5, 1995.
170. Wilson LC, Leverton K, Oude Luttikhuis ME, Oley CA, Flint J, Wolstenholme J. Brachydactyly and mental retardation: An Albright hereditary osteodystrophy-like syndrome localized to 2q37. Am J Hum Genet 56: 400-7, 1995.
171. Woon CW, Soparkar S, Heasley L, Johnson GL. Expression of a Gαs/Gai chimera that constitutively activates cAMP synthesis. J Biol Chem 264: 5687-93, 1989.
172. Yoshimoto K, Iwahana H, Fukada A, Sano T, Itakura M. Rare mutations of the Gs α subunit gene in human endocrine tumors. Mutation detecteced by polymerase chain reaction-primer-introduced restriction analysis. Cancer 72: 1386-93, 1993.
173. Yoshimoto M, Nakayama M, Baba T, Uehara Y, Niikawa N, Ito M. A case of neonatal McCune-Albright syndrome with Cushing syndrome and hyperthyroidism. Acta Pediatr Scand 80: 984-87, 1991.
174. Zung A, Chalew SA, Schwindinger WF, Levine MA. Response to PTH(1-34) is altered in patients with McCune-Albright syndrome. J Bone Miner Res 8: S228, 1993.